申请人:Calitor Sciences, LLC
公开号:US08975282B2
公开(公告)日:2015-03-10
The present invention provides novel substituted pyrazolone compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
本发明提供了新型取代吡唑酮化合物、药用可接受盐及其制剂,用于调节蛋白酪氨酸激酶活性以及调节细胞活动,例如增殖、分化、凋亡、迁移和侵袭。本发明还提供了包含这种化合物的药用可接受组合物以及使用这些组合物在哺乳动物,特别是人类的治疗过度增殖性疾病的方法。